Events Archive

Bicoll is taking part and is one of the sponsors of the second international Helmholtz Drug Discovery Conference, April 26-27, 2018 at Helmholtz Zentrum München. Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss with academic experts and scientists from biotech and pharmaceutical industries. Topics include innovative screens on …

Dr. Kai Lamottke takes part as a speaker at EU Industry Day on the 23d of February. During the talk he points out the way to improve the EU support for SMEs. EU Industry Day update stakeholders on the Commission’s strategic approach to industrial policy and actions to further develop industrial competitiveness in Europe. It is a …

Seoul, December 14, 2017 – Dr. Maria Lamottke has joined the promotion meeting at Chungbuk Technopark.  It was a chance to get to know the potential partners and market in South Korea, build up the connections and present Bicoll. Chungbuk Technopark are a non-profit government organization playing a key role between local community and have …

Dresden, December 6-7, 2017 – Bicoll CEO has participated in 19. CEO & CFO meeting in Dresden, organized by Bio Deutschland e.V. During the conference he has shortly presented the company as well as the last achievements of 2017. It was a great pleasure to meet new faces and greet the familiar ones. Read more …

Bicoll is participant at Osaka Biotech & Pharma Partnering Conference taking place on the 10th of October in Osaka. The business matching event is reserved only to European Union companies from the following organisations that are involved in the conference: EU-Japan Centre for Industrial Cooperation, Advantage Austria, BioM Biotech Cluster Development GmbH, Bio Turku, bioXclusters …

Dr. Kai Lamottke presents the last results of the drug discovery development during the monthly IZB brunch on the 20th of July at the leading European biotech cluster. Read the program here.  

Bicoll Managing Director, Dr. Kai Lamottke, hosts at Bicoll headquaters Max-Plank InPharma Innovation Initiative  3Is.

Bicoll Managing Director, Dr. Kai Lamottke, joins Steering Committee of EpimiRNA in Amsterdam to discuss the achievements in epilepsy research. Read more in  EpimiRNA publications.

Bicoll takes part in the 29th Natural Compounds days Naturstofftage, Bavaria, Germany.

Bicoll as a work package leader  is visiting Copenhagen, Denmark as a part of Epilepsy Consortium  EpimiRNA. Read more about the last results on the topic of epilepsy treatment.